An HPLC method for the measurement of 5-fluorouracil in human plasma with a low detection limit and a high extraction yieldM A Nassim, Rakesh Goel, Farshad H. Shirazi et al.|International Journal of Molecular Medicine|2002Cited by 27
Eastern Canadian Colorectal Cancer Consensus Conference: Setting the Limits of Resectable DiseaseMichael M. Vickers, Timothy R. Asmis, Benoît Samson et al.|Current Oncology|2010Cited by 22
Final clinical and pharmacokinetic (PK) results from a phase 1 study of the novel N-cadherin (N-cad) antagonist, Exherin (ADH-1), in patients with refractory solid tumors stratified according to N-cad expressionDavid J. Stewart, W. P. Peters, Derek J. Jonker et al.|Journal of Clinical Oncology|2006Cited by 14
Real-Life Treatment of Metastatic Colorectal Cancer with Regorafenib: A Single-Centre ReviewJoanna Gotfrit, Rachel Goodwin, Michael M. Vickers et al.|Current Oncology|2017Cited by 12
A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal CancerJean A. Maroun, G. Chiritescu, Horia Marginean et al.|Clinical Colorectal Cancer|2017Cited by 9